Skip to content

Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health

Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01353807
Enrollment
533
Registered
2011-05-16
Start date
1989-11-30
Completion date
2011-05-31
Last updated
2014-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopy, Metabolic Syndrome, Preterm Delivery

Keywords

Fish oil, Pregnancy, RCT, Birth weight, Gestational age, Asthma and allergies, Metabolic syndrome, Obesity

Brief summary

The aim of the trial is to investigate the effect of daily supplementation with 2.7 grams of long chain n-3 fatty acids during the third trimester of pregnancy. In 1990, 533 pregnant women, while they were in gestational week 30, were randomized to fish oil supplements providing the mentioned amount of long chain n-3 fatty acids, olive oil supplements, or no supplements; they were asked to take the supplements until delivery. Health outcomes were assessed during pregnancy and delivery. Further, offspring health and development has been examined during the ensuring two decades by making linkages to the rich Danish health and administrative registries, by asking the offspring to complete web-based questionnaires, and by examining the offspring physically.

Interventions

DIETARY_SUPPLEMENTFish oil

4 1-g gelatine capsules per day providing 2,7 grams long chain n-3 fatty acids

DIETARY_SUPPLEMENTOlive oil

4 1-g gelatine capsules with virgin olive oil

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
The Danish Council for Strategic Research
CollaboratorOTHER
Danish Council for Independent Research
CollaboratorOTHER
Lundbech Foundation
CollaboratorUNKNOWN
EU Commision, DG12
CollaboratorUNKNOWN
Centre for Fetal Programming, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy pregnant women in gestation week 30

Exclusion criteria

* Bleeding episodes during pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Gestation length1989-1990 (1 year)We assesed impact of fish oil supplementation in pregnancy on timing of spontaneous delivery

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026